MANGALAM — Mangalam Drugs and Organics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Annual balance sheet for Mangalam Drugs and Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	5.92	19.5	99.9	10.1	25.9
Net Total Accounts Receivable
Net Total Receivables	543	465	466	703	534
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,339	1,825	2,066	1,998	1,990
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,142	1,268	1,336	1,265	1,336
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,641	3,284	3,596	3,571	3,664
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,091	1,301	1,654	1,810	1,916
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,333	1,779	2,077	2,148	2,174
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	1,308	1,506	1,520	1,423	1,490
Total Liabilities & Shareholders' Equity	2,641	3,284	3,596	3,571	3,664
Total Common Shares Outstanding